No Changes in Functional Connectivity After Dimethyl Fumarate Treatment in Multiple Sclerosis.
Claudia PiervincenziEmilia SbardellaMarta AltieriAntonio IannielloPatrizia PantanoCarlo PozzilliNikolaos PetsasPublished in: Neurology and therapy (2022)
The absence of FC changes could be due to the low degree of baseline inflammation in our patients, though we cannot exclude that more time may be required to observe such changes. No FC changes may reflect a beneficial effect of DMF therapy, as supported by conventional MRI findings and clinical improvement.
Keyphrases
- functional connectivity
- multiple sclerosis
- resting state
- end stage renal disease
- newly diagnosed
- ejection fraction
- magnetic resonance imaging
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- stem cells
- computed tomography
- magnetic resonance
- patient reported outcomes
- patient reported
- replacement therapy
- smoking cessation